Macquarie Group’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.4M | Buy |
144,038
+34,168
| +31% | +$7.36M | 0.18% | 108 |
|
|
2025
Q4 | $22.6M | Sell |
109,870
-153,617
| -58% | -$28.9M | 0.1% | 167 |
|
|
2025
Q3 | $41.4M | Sell |
263,487
-15,030
| -5% | -$2.32M | 0.05% | 476 |
|
|
2025
Q2 | $46.8M | Sell |
278,517
-18,177
| -6% | -$2.7M | 0.06% | 431 |
|
|
2025
Q1 | $40.9M | Sell |
296,694
-48,493
| -14% | -$6.18M | 0.05% | 458 |
|
|
2024
Q4 | $39.7M | Buy |
345,187
+276,199
| +400% | +$32.2M | 0.05% | 474 |
|
|
2024
Q3 | $7.62M | Sell |
68,988
-5,610
| -8% | -$587K | 0.01% | 869 |
|
|
2024
Q2 | $7.33M | Sell |
74,598
-16,464
| -18% | -$1.68M | 0.01% | 878 |
|
|
2024
Q1 | $10.2M | Buy |
91,062
+24,163
| +36% | +$2.61M | 0.01% | 820 |
|
|
2023
Q4 | $6.74M | Sell |
66,899
-2,449
| -4% | -$243K | 0.01% | 903 |
|
|
2023
Q3 | $6.02M | Buy |
69,348
+15,868
| +30% | +$1.43M | 0.01% | 880 |
|
|
2023
Q2 | $5.06M | Sell |
53,480
-5,617
| -10% | -$474K | 0.01% | 926 |
|
|
2023
Q1 | $4.35M | Sell |
59,097
-37,845
| -39% | -$2.86M | 0.01% | 959 |
|
|
2022
Q4 | $7.45M | Sell |
96,942
-110,320
| -53% | -$8.38M | 0.01% | 898 |
|
|
2022
Q3 | $13.8M | Sell |
207,262
-69,246
| -25% | -$4.39M | 0.02% | 758 |
|
|
2022
Q2 | $14.5M | Sell |
276,508
-56,482
| -17% | -$3.21M | 0.02% | 775 |
|
|
2022
Q1 | $18.9K | Sell |
332,990
-18,053
| -5% | -$967K | 0.01% | 780 |
|
|
2021
Q4 | $18.1M | Sell |
351,043
-7,216,125
| -95% | -$354M | 0.02% | 779 |
|
|
2021
Q3 | $374M | Sell |
7,567,168
-2,829,261
| -27% | -$153M | 0.32% | 63 |
|
|
2021
Q2 | $594M | Sell |
10,396,429
-677,188
| -6% | -$39.6M | 0.49% | 45 |
|
|
2021
Q1 | $673M | Sell |
11,073,617
-1,021,547
| -8% | -$56.4M | 0.95% | 27 |
|
|
2020
Q4 | $648M | Sell |
12,095,164
-225,196
| -2% | -$11.7M | 0.95% | 33 |
|
|
2020
Q3 | $578M | Sell |
12,320,360
-292,600
| -2% | -$15M | 0.98% | 31 |
|
|
2020
Q2 | $658M | Sell |
12,612,960
-1,111,067
| -8% | -$57.3M | 1.13% | 28 |
|
|
2020
Q1 | $658M | Sell |
13,724,027
-3,553,540
| -21% | -$185M | 1.35% | 16 |
|
|
2019
Q4 | $874M | Buy |
17,277,567
+1,774,715
| +11% | +$91.7M | 1.25% | 29 |
|
|
2019
Q3 | $732M | Buy |
15,502,852
+766,315
| +5% | +$35M | 1.23% | 29 |
|
|
2019
Q2 | $694M | Buy |
14,736,537
+742,724
| +5% | +$34.3M | 1.17% | 28 |
|
|
2019
Q1 | $674M | Buy |
13,993,813
+402,707
| +3% | +$20.2M | 1.15% | 33 |
|
|
2018
Q4 | $606M | Sell |
13,591,106
-273,571
| -2% | -$14.3M | 1.17% | 30 |
|
|
2018
Q3 | $749M | Buy |
13,864,677
+1,320,410
| +11% | +$67.6M | 1.22% | 21 |
|
|
2018
Q2 | $613M | Buy |
12,544,267
+2,067,829
| +20% | +$117M | 1.06% | 33 |
|
|
2018
Q1 | $657M | Sell |
10,476,438
-149,073
| -1% | -$10.2M | 1.2% | 28 |
|
|
2017
Q4 | $651M | Buy |
10,625,511
+520,137
| +5% | +$32.2M | 1.15% | 30 |
|
|
2017
Q3 | $676M | Buy |
10,105,374
+445,399
| +5% | +$31.5M | 1.21% | 32 |
|
|
2017
Q2 | $753M | Sell |
9,659,975
-208,144
| -2% | -$15.7M | 1.38% | 20 |
|
|
2017
Q1 | $805M | Sell |
9,868,119
-210,500
| -2% | -$16.6M | 1.46% | 12 |
|
|
2016
Q4 | $725M | Buy |
10,078,619
+917,027
| +10% | +$66.3M | 1.39% | 31 |
|
|
2016
Q3 | $712M | Sell |
9,161,592
-8,820,040
| -49% | -$713M | 1.37% | 28 |
|
|
2016
Q2 | $1.4B | Buy |
17,981,632
+9,986,636
| +125% | +$796M | 1.37% | 30 |
|
|
2016
Q1 | $655M | Buy |
7,994,996
+755,217
| +10% | +$61.4M | 1.32% | 26 |
|
|
2015
Q4 | $646M | Sell |
7,239,779
-41,247
| -0.6% | -$3.5M | 1.33% | 11 |
|
|
2015
Q3 | $559M | Buy |
7,281,026
+212,320
| +3% | +$17.7M | 1.2% | 24 |
|
|
2015
Q2 | $591M | Buy |
7,068,706
+336,469
| +5% | +$29.7M | 1.17% | 23 |
|
|
2015
Q1 | $608M | Sell |
6,732,237
-14,307
| -0.2% | -$1.23M | 1.19% | 9 |
|
|
2014
Q4 | $545M | Buy |
6,746,544
+273,382
| +4% | +$21.6M | 1.12% | 20 |
|
|
2014
Q3 | $485M | Buy |
6,473,162
+242,120
| +4% | +$17.6M | 1.04% | 26 |
|
|
2014
Q2 | $427M | Buy |
6,231,042
+159,765
| +3% | +$10.9M | 0.95% | 32 |
|
|
2014
Q1 | $425M | Sell |
6,071,277
-286,254
| -5% | -$19.9M | 0.73% | 47 |
|
|
2013
Q4 | $425M | Sell |
6,357,531
-292,472
| -4% | -$17.9M | 0.76% | 31 |
|
|
2013
Q3 | $347M | Buy |
6,650,003
+112,485
| +2% | +$5.71M | 0.68% | 52 |
|
|
2013
Q2 | $309M | Buy |
+6,537,518
| New | +$299M | 0.67% | 51 |
|
Other funds holding CAH
VCM
VPM
Macquarie Group's CAH Position: Q1 2026 in Review
Macquarie Group increased its Cardinal Health (CAH) stake by 31% in Q1 2026, buying an estimated $7.36M and bringing the position to 144,038 shares worth $30.4M. The position accounts for 0.18% of the portfolio, ranked #108.
Macquarie Group first reported a position in CAH in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.4B in Q2 2016. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Macquarie Group held 144,038 shares of Cardinal Health worth $30.4M as of Q1 2026.
- Macquarie Group bought 34,168 Cardinal Health shares in Q1 2026, an estimated $7.36M.
- Cardinal Health made up 0.18% of Macquarie Group's portfolio in Q1 2026, its #108 holding.
- Macquarie Group first reported a position in Cardinal Health in Q2 2013 and has held it in 52 quarters since.
- Macquarie Group's Cardinal Health position peaked at $1.4B in Q2 2016.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Macquarie Group's 13F filing for Q1 2026, filed 15 May 2026.